ArticleClinical and translational medicine2024

Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.

Zi-Yang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.